摘要
目的:评价玻璃体切除联合白内障手术治疗复杂性视网膜脱离的疗效和安全性。方法:回顾性病例系列研究。复杂性玻璃体视网膜疾病患者143例162眼接受玻璃体切除联合白内障手术治疗。主要结果包括术后视力和并发症。结果:术后随访时间平均26.2mo。主要病因包括视网膜脱离、增生性糖尿病视网膜病变、黄斑疾病等。术后1,6,12,18,24mo与术前比较视力提高≥2行分别为86眼(53.1%)、89眼(54.9%)、87眼(53.7%)、93眼(57.2%)和101眼(62.3%)。结论:玻璃体切除联合白内障手术治疗复杂性玻璃体视网膜疾病是一种有效、安全的手术。
AIM： To evaluate the long - term results of visual outcomes and safety of phacovitrectomy with intraocular lens implantation in the treatment of complex vitreoretinal diseases. METHODS： A retrospective analysis was performed in case series. Totally 143 eyes of 162 patients underwent phacovitrectomy and intraocular lens implantation. Main outcome measures were visual acuity and operative complications. RESULTS：The mean follow-up was 26. 2mo. The main vitreoretinal surgical indications were retinal detachment, proliferative diabetic retinopathy and macula disease. In total, 86 eyes （ 53. 1%）, 89 eyes （ 54. 9%）, 87 eyes （53.7%）, 93 eyes （57. 2%） and 101 eyes （62. 3%） gained two or more lines of vision compared with baseline, at 1mo, 6mo, 12mo, 18mo and 24mo follow-up. CONCLUSION： Phacovitrectomy and intraocular lens implantation is safely and effectively used for cataracts and complex vitreoretinal diseases.
出处
《国际眼科杂志》
CAS
2014年第5期952-953,共2页
International Eye Science
